Benjamin Lang

2.1k citations

62 papers · 1.5k indexed · h-index 21

Impact in

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 5%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases

Papers in ⓘ

Internal Medicine 3
Hepatology 6
- Hepatitis C virus research 6

Co-authors: Stuart K. Calderwood (18 shared papers)Viktoria Moschetti (9 shared papers)Stephan Glund (8 shared papers)Joachim Stangier (7 shared papers)Paul Reilly (6 shared papers)Michael Schmohl (5 shared papers)Stephen H. Norris (6 shared papers)Steven Ramael (6 shared papers)
Journals: Cell Stress and Chaperones (4 papers)Frontiers in Immunology (3 papers)Journal of Investigative Dermatology (2 papers)Cancers (2 papers)Cells (2 papers)
Partner nations: United States Germany Japan

In The Last Decade

Benjamin Lang

60 papers receiving 1.4k citations

Peers

Countries citing papers authored by Benjamin Lang

Since Specialization

Citations

This map shows the geographic impact of Benjamin Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Lang more than expected).

Fields of papers citing papers by Benjamin Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Lang. The network helps show where Benjamin Lang may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Lang Line = papers co-authored together Benjamin Lang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial The Lancet ·Stephan Glund, Joachim Stangier, Michael Schmohl, Dietmar Ganßer, Stephen H. Norris, Joanne van Ryn, Benjamin Lang, Steven Ramael, Viktoria Moschetti, Fredrik Gruenenfelder, Paul Reilly, Jörg Kreuzer	2015	237
2	A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran Thrombosis and Haemostasis ·Viktoria Moschetti, Stephen H. Norris, Joachim Stangier, Michael Schmohl, Joanne van Ryn, Benjamin Lang, Steven Ramael, Paul Reilly, Stephan Glund	2015	183
3	The functions and regulation of heat shock proteins; key orchestrators of proteostasis and the heat shock response Archives of Toxicology ·Benjamin Lang, M. Barrientos Guerrero, Thomas L. Prince, Yuka Okusha, Cristina Bonorino, Stuart K. Calderwood	2021	96
4	Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond International Journal of Molecular Sciences ·Benjamin Lang, Martin E. Guerrero-Gimenez, Thomas L. Prince, Andrew Ackerman, Cristina Bonorino, Stuart K. Calderwood	2019	65
5	HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors Biochemical Journal ·A. Gabrielle J. van der Kraan, Ryan C. Chai, Preetinder P. Singh, Benjamin Lang, Jiake Xu, Matthew T. Gillespie, John T. Price, Julian M.W. Quinn	2013	60
6	Idarucizumab, a Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Elderly and Renally Impaired Subjects Blood ·Stephan Glund, Joachim Stangier, Michael Schmohl, Viktoria Moschetti, Wouter Haazen, Marina De Smet, Dietmar Ganßer, Stephen H. Norris, Benjamin Lang, Paul Reilly	2014	59
7	Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells Cells ·Takanori Eguchi, Chiharu Sogawa, Kisho Ono, Masaki Matsumoto, Manh Tien Tran, Yuka Okusha, Benjamin Lang, Kuniaki Okamoto, Stuart K. Calderwood	2020	59
8	Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study Clinical Pharmacokinetics ·Stephan Glund, Joachim Stangier, Joanne van Ryn, Michael Schmohl, Viktoria Moschetti, Wouter Haazen, Marina De Smet, Dietmar Ganßer, Stephen H. Norris, Benjamin Lang, Paul Reilly, Jörg Kreuzer	2016	58
9	Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis Journal of Allergy and Clinical Immunology ·Patrick Baum, Sudha Visvanathan, Sandra Garcet, Janine Roy, Ramona Schmid, Sebastian Bossert, Benjamin Lang, H. Bachelez, Robert Bissonnette, Christian Thoma, James G. Krueger	2021	52
10	Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects Expert Opinion on Investigational Drugs ·Christopher Wynne, Mario Altendorfer, Ivo Sonderegger, Lien Gheyle, R. B. Ellis‐Pegler, Susanne Buschke, Benjamin Lang, Deepak Assudani, Sandeep N. Athalye, Niklas Czeloth	2016	50
11	HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity Cells ·Thomas L. Prince, Benjamin Lang, Martin E. Guerrero-Gimenez, Juan Manuel Fernandez-Muñoz, Andrew Ackerman, Stuart K. Calderwood	2020	47
12	Abstract 17765: A Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Healthy Male Volunteers Circulation ·Stephan Glund, Joachim Stangier, Michael Schmohl, Marina De Smet, Dietmar Ganßer, Benjamin Lang, Viktoria Moschetti, Steven Ramael, Paul Reilly	2013	41
13	The Scavenger Receptor SREC-I Cooperates with Toll-Like Receptors to Trigger Inflammatory Innate Immune Responses Frontiers in Immunology ·Ayesha Murshid, Thiago J. Borges, Benjamin Lang, Stuart K. Calderwood	2016	31
14	Heat shock proteins in cell signaling and cancer Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Benjamin Lang, Thomas L. Prince, Yuka Okusha, Heeyoun Bunch, Stuart K. Calderwood	2021	29
15	MZF1 and SCAND1 Reciprocally Regulate CDC37 Gene Expression in Prostate Cancer Cancers ·Takanori Eguchi, Thomas L. Prince, Manh Tien Tran, Chiharu Sogawa, Benjamin Lang, Stuart K. Calderwood	2019	26
16	A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects Expert Opinion on Investigational Drugs ·Willem Hettema, Christopher Wynne, Benjamin Lang, Mario Altendorfer, Niklas Czeloth, Ragna Lohmann, Sandeep N. Athalye, Dorothee E. Schliephake	2017	23
17	Heat stress induces epithelial plasticity and cell migration independent of heat shock factor 1 Cell Stress and Chaperones ·Benjamin Lang, Linh T. Nguyen, Hai-Anh Nguyen, Jessica Vieusseux, Ryan C. Chai, Christopher Christophi, Theodora Fifis, Michelle M. Kouspou, John T. Price	2012	22
18	Immunological Outcomes Mediated Upon Binding of Heat Shock Proteins to Scavenger Receptors SCARF1 and LOX-1, and Endocytosis by Mononuclear Phagocytes Frontiers in Immunology ·Ayesha Murshid, Thiago J. Borges, Cristina Bonorino, Benjamin Lang, Stuart K. Calderwood	2020	22
19	Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial American Journal of Clinical Dermatology ·Alan Menter, Stanley Cohen, Jonathan Kay, Vibeke Strand, Alice B. Gottlieb, Stephen B. Hanauer, Sravan Kumar Eduru, Susanne Buschke, Benjamin Lang, Karl‐Heinz Liesenfeld, Jennifer Schaible, Dorothy McCabe	2022	20
20	Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner Journal of Biological Chemistry ·Ryan C. Chai, Michelle M. Kouspou, Benjamin Lang, Chau H. Nguyen, A. Gabrielle J. van der Kraan, Jessica Vieusseux, R. Lim, Matthew T. Gillespie, Ivor J. Benjamin, Julian M.W. Quinn, John T. Price	2014	20

About Benjamin Lang

Benjamin Lang is a scholar working on Internal Medicine, Hepatology, Immunology, Statistics and Probability and Aging, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include Heat shock proteins research (20 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Endoplasmic Reticulum Stress and Disease (7 papers), Pharmaceutical studies and practices (6 papers), Atrial Fibrillation Management and Outcomes (6 papers), Biosimilars and Bioanalytical Methods (6 papers), Hepatitis C virus research (6 papers) and Statistical Methods in Clinical Trials (5 papers). The work is most often cited by research in Internal Medicine (376 citations), Cardiology and Cardiovascular Medicine (535 citations), Immunology (270 citations), Aging (19 citations) and Molecular Biology (503 citations). Benjamin Lang has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Stuart K. Calderwood, Viktoria Moschetti, Stephan Glund, Joachim Stangier, Paul Reilly, Michael Schmohl, Stephen H. Norris, Steven Ramael, Thomas L. Prince and Joanne van Ryn. Their work appears in journals such as Cell Stress and Chaperones, Frontiers in Immunology, Journal of Investigative Dermatology, Cancers and Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact